EndoChoice

EndoChoice, Inc. is a medical technology company founded in 2008 and located near Atlanta, Georgia. The company specializes in innovative endoscopy solutions for gastrointestinal (GI) care. EndoChoice develops and commercializes advanced endoscopic imaging systems, devices, infection control products, and pathology services aimed at specialists treating various GI conditions, including colon cancer. The product portfolio includes a range of endoscopes for gastrointestinal endoscopy, colonoscopy, gastroscopy, and enteroscopy. A notable product is the Full Spectrum Endoscopy System (Fuse®), which enhances visualization and lesion detection during colonoscopies. Additionally, EndoChoice offers complementary accessories and single-use devices, such as resection and retrieval devices, needles, and infection control kits. The company serves over 2,500 customers, including hospitals and clinics across the United States, and collaborates with distribution partners in approximately 30 countries. In 2016, EndoChoice was acquired by Boston Scientific, integrating its innovative offerings into a broader platform for GI care solutions.

• Employees 74
• Founded 2008
• Annual Revenue $55260000
• Total Funding $215600000